A Comparison Between Wireless CROS and
Bone-anchored Hearing Devices for Single-sided
Deafness: A Pilot Study
*Jennifer Finbow, *
†
Manohar Bance, *Steve Aiken,
‡
Mark Gulliver,
‡
Janine Verge, and *Rachel Caissie
*Dalhousie University, Halifax;
Þ
QEII Health Sciences Center, Halifax; and
þ
Nova Scotia Hearing and Speech
Centres, Halifax, Nova Scotia, Canada
Introduction:
This study compared wireless Contralateral
Routing of Signals (CROS) hearing aid and bone-anchored
hearing device (BAHD) in patients with single-sided deafness.
Methods:
Eight adults with single-sided deafness previously
implanted with a BAHD were given a 2-week trial with a CROS
hearing aid and tested in unaided and aided conditions. Both
devices were compared on head shadow effect reduction, speech
perception measures in quiet and in noise, self-assessment
questionnaires, and daily diaries.
Results:
Both the CROS and BAHD significantly reduced the
head shadow effect. QuickSIN scores were significantly better
with noise presented to the poorer ear, as compared to the better
ear, for the unaided condition, the BAHD, and the CROS.
Scores showed no significant differences between the CROS
and BAHD with noise presented to the better ear, but scores
with the CROS were significantly poorer than in the unaided
condition with noise presented to the poorer ear. There were
no significant differences between BAHD and CROS for the
ratings on the Bern Benefit in Single-Sided Deafness and
Speech Spatial Qualities questionnaires. Both devices were
worn an average of 10 hours per day. Four participants pre-
ferred the CROS for sound quality; three preferred the BAHD
for comfort.
Conclusion:
Comparisons of CROS and BAHD need to be
re-evaluated as both technologies have evolved. In our pilot
study, both devices seem comparable, with the CROS avoid-
ing the risks of surgery, and we recommend a trial of CROS
in our center for first line treatment of single-sided deafness.
Key Words:
BAHD
V
Bone-anchored hearing device
V
Contralateral routing of signals
V
CROS
V
Single-sided deafness
V
Unilateral hearing loss.
Otol Neurotol
36:
819
Y
825, 2015.
Unilateral sensorineural hearing loss or single-sided
deafness (SSD) results in several communication diffi-
culties particularly in noisy situations (1). These diffi-
culties stem from the loss of binaural hearing and the head
shadow effect, in which the good ear is shielded from
sounds from the side of the poorer ear (2).
Currently, there are two main intervention methods
(SSD aids) used worldwide to help alleviate the head
shadow effect: the Contralateral Routing of Signals (CROS)
hearing aid and the bone-anchored hearing device (BAHD),
which routes sound to the better ear by transcranial bone
conduction from a microphone/processor attached to an
osseointegrated implant in the skull on the poor hearing
ear side. Neither restores hearing to the affected ear, but
rather alleviates the head shadow effect. Other, newer
interventions for SSD include cochlear implantation (3,4)
and the SoundBite (5). These devices will not be dis-
cussed in this article.
For several decades, the CROS was the traditional in-
tervention approach, with older CROS models consisting
of an analog hearing aid on each ear connected together
by a wire along the neck of the patient (6,7). Newer
CROS models are wireless and new CROS and BAHD
models include more sophisticated digital noise reduction
and adaptive directional microphones (8,9). Previous
studies have compared older models of CROS to older
models of BAHD, but both technologies have improved
substantially, especially the CROS.
It is well established that the CROS and BAHD do not
improve sound localization abilities for people with SSD
(10
Y
18). However, the benefits of the devices for the
improvement of communication are not as well under-
stood, as indicated by conflicting results in the literature.
Address correspondence and reprint requests to Rachel Caissie, Ph.D.,
Associate Professor, School of Human Communication Disorders,
Dalhousie University, 1256 Barrington St., 6th floor, P.O. Box 15000,
Halifax, Nova Scotia, B3H 4R2, Canada; E-mail:
rcaissie@dal.caThe authors report no conflicts of interest.
Source of Funding: Nova Scotia Health and Research Foundation.
Otology & Neurotology
36:
819
Y
825 2015, Otology & Neurotology, Inc.
Reprinted by permission of Otol Neurotol. 2015; 36(5):819-825.
148




